Neuland Labs.

71
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE794A01010
  • NSEID: NEULANDLAB
  • BSEID: 524558
INR
16,920.00
-68.5 (-0.4%)
BSENSE

Dec 05

BSE+NSE Vol: 18.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
1,476.00
1,558.00
1,191.00
951.00
936.00
762.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,476.00
1,558.00
1,191.00
951.00
936.00
762.00
Expenditure (Ex Depriciation)
Stock Adjustments
12.00
-55.00
-9.00
-15.00
-1.00
-11.00
Raw Materials Consumed
574.00
632.00
487.00
437.00
439.00
391.00
Power & Fuel Cost
50.00
48.00
48.00
42.00
39.00
32.00
Employee Cost
272.00
257.00
201.00
182.00
149.00
123.00
Operating Expenses
112.00
107.00
86.00
89.00
81.00
64.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
23.00
21.00
29.00
27.00
30.00
18.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
22.00
10.00
22.00
9.00
11.00
13.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,153.00
1,095.00
919.00
808.00
790.00
660.00
Operating Profit (PBDIT) excl Other Income
323.00
462.00
271.00
142.00
146.00
101.00
Other Income
20.00
12.00
9.00
2.00
16.00
3.00
Operating Profit (PBDIT)
343.00
475.00
281.00
144.00
162.00
105.00
Interest
8.00
13.00
13.00
13.00
17.00
21.00
Profit before Depriciation and Tax
335.00
461.00
268.00
131.00
145.00
84.00
Depreciation
65.00
59.00
52.00
49.00
39.00
31.00
Profit Before Taxation & Exceptional Items
269.00
401.00
215.00
82.00
105.00
52.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
346.00
401.00
215.00
82.00
105.00
52.00
Provision for Tax
86.00
101.00
52.00
18.00
24.00
36.00
Profit After Tax
260.00
300.00
163.00
63.00
80.00
16.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
752.00
465.00
308.00
248.00
170.00
159.00
Profit Available for appropriations
1,012.00
765.00
471.00
311.00
250.00
175.00
Appropriations
1,012.00
765.00
471.00
311.00
250.00
175.00
Equity Dividend (%)
120.00%
140.00%
100.00%
50.00%
50.00%
20.00%
Earnings Per Share
202.74
233.89
127.45
49.74
62.85
12.63
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -5.24% vs 30.84% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -30.12% vs 70.17% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -40.72% vs 7.12% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -13.32% vs 83.51% in Mar 2024

Compare Profit and Loss Results of Neuland Labs.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,476.00
0
1,476.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
1,476.00
0
1,476.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
12.00
0
12.00
0%
Raw Materials Consumed
574.00
0
574.00
0%
Power & Fuel Cost
50.00
0
50.00
0%
Employee Cost
272.00
0
272.00
0%
Operating Expenses
112.00
0
112.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
23.00
0
23.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
22.00
0
22.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
1,153.00
0
1,153.00
0%
Operating Profit (PBDIT) excl Other Income
323.00
0.00
323.00
0%
Other Income
20.00
0
20.00
0%
Operating Profit (PBDIT)
343.00
0
343.00
0%
Interest
8.00
0
8.00
0%
Profit before Depriciation and Tax
335.00
0
335.00
0%
Depreciation
65.00
0
65.00
0%
Profit Before Taxation & Exceptional Items
269.00
0
269.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
346.00
0
346.00
0%
Provision for Tax
86.00
0
86.00
0%
Profit After Tax
260.00
0
260.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
752.00
0
752.00
0%
Profit Available for appropriations
1,012.00
0
1,012.00
0%
Appropriations
1,012.00
0
1,012.00
0%
Equity Dividend (%)
120%
0%
120.00
Earnings Per Share
202.74
0
202.74
0%
Profit And Loss - Net Sales
Net Sales 1,476.84 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.24% vs 30.84% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 323.26 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -30.12% vs 70.17% in Mar 2024

Profit And Loss - Interest
Interest 8.30 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -40.72% vs 7.12% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 260.11 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -13.32% vs 83.51% in Mar 2024